Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem/Stromal Cells
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Cell Culture Media & Supplements
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Exosomes/Extracellular Vesicles
      • Media & Supplements
      • cGMP CliniControl™ Production Media
      • Xeno-free Exosomes
    • Genetic Engineering Tools
      • Genetic Engineering Media
      • cGMP CliniControl™ Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor Screening Kits
      • hMSC Tissue Screening Kits
      • Bioreactor Kits & Bundles
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem/Stromal Cells
      • Cell Culture Media & Supplements
      • Exosome/Extracellular Vesicle Production Media
      • Genetic Engineering Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Press Releases

RoosterBio Launches New cGMP Stem Cell Product Portfolio, Maintaining Unwavering Commitment to Driving the Explosive Regenerative Medicine Industry.

September 14, 2017

Stem Cell Exomere Program announced by RoosterBio and Exopharm.

August 7, 2017

Margot Connor, CEO, RoosterBio Inc., Frederick Innovative Technology Center, Inc expected graduate earns “Top 10” Technology Industry Award.

July 27, 2017

RoosterBio Launches a Xeno-Free Bioreactor Feed to Streamline Cell Expansion & Efficiently Reach Billions of hMSCs.

July 6, 2017

RoosterBio Graduates From Frederick’s Business Incubator

July 3, 2017

RoosterBio Launches the Regenerative Medicine Industry’s First Xeno-Free hMSC Cell Banks to Advance and Simplify Stem Cell Biomanufacturing.

May 5, 2017

Wake Forest Baptist Institute Leads Effort to Advance Manufacturing of Regenerative Medicine Therapies.

March 31, 2017

RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network.

January 18, 2017

Pall Corporation and RoosterBio, Inc. Announce Collaboration Agreement to Market Mesenchymal Stem/Stromal Cells and Bioreactor Expansion Systems

October 5, 2016

BioBridge Global-led biotech team awarded $7.8 million Army contract. Funds will help develop capability for large-scale manufacturing of stem cells for research and patient use.

October 3, 2016
Previous 1 2 3 4 5 6 7 8 Next

Sidebar Navigation

  • News
  • Events
  • Press Releases
  • Media Kit

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem/Stromal Cells
    • Cell Culture Media & Supplements
    • Exosomes/Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2023 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Enforme Interactive, Inc.

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email